Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0200
-0.0100
(-33.33%)
At close: February 21 at 1:04:51 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
21
101
97
221
96
Cost of Revenue
61
159
90
186
56
Gross Profit
-39
-58
7
35
40
Operating Expense
168
1,393
2,043
1,758
696
Operating Income
-207
-1,451
-2,036
-1,723
-656
Net Non Operating Interest Income Expense
327
306
--
-384
-3
Other Income Expense
--
60
84
-54
4
Pretax Income
180
-1,085
-1,952
-2,161
-655
Net Income Common Stockholders
180
-1,085
-1,952
-2,161
-655
Diluted NI Available to Com Stockholders
180
-1,085
-1,952
-2,161
-655
Basic EPS
0.01
-0.04
-0.09
-0.10
-0.03
Diluted EPS
0.01
-0.04
-0.09
-0.10
-0.03
Basic Average Shares
25,593.1330
23,824.7980
23,080.7550
21,721.3990
21,721.3990
Diluted Average Shares
25,593.1330
23,824.7980
23,080.7550
21,721.3990
21,721.3990
Total Operating Income as Reported
-207
-1,451
-2,036
-1,723
-656
Total Expenses
229
1,552
2,133
1,944
752
Net Income from Continuing & Discontinued Operation
180
-1,085
-1,952
-2,161
-655
Normalized Income
133.8000
-1,145
-2,036
-2,107
-659
Interest Income
--
--
--
19
4
Interest Expense
2
23
--
11
--
Net Interest Income
327
306
--
-384
-3
EBIT
182
-1,062
-2,036
-2,150
-655
EBITDA
189
-1,055
-2,030
-2,149
-655
Reconciled Cost of Revenue
61
159
90
186
56
Reconciled Depreciation
7
7
6
1
--
Net Income from Continuing Operation Net Minority Interest
180
-1,085
-1,952
-2,161
-655
Total Unusual Items Excluding Goodwill
60
60
84
-54
4
Total Unusual Items
60
60
84
-54
4
Normalized EBITDA
129
-1,115
-2,114
-2,095
-659
Tax Rate for Calcs
0.0002
--
--
--
--
Tax Effect of Unusual Items
13.8000
--
--
--
--
12/31/2020 - 3/8/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVT.VI Evotec SE
8.50
-0.82%
N4P.L N4 Pharma Plc
0.5750
0.00%
BOI.PA Boiron SA
25.20
+1.00%
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%
RJF.MC Laboratorio Reig Jofre, S.A.
2.6900
+1.13%
APH.L Alliance Pharma plc
60.80
+0.33%
DICOT.ST Dicot Pharma AB
0.2655
+1.53%
PHO.OL Photocure ASA
51.50
-0.39%
BIOG-B.ST BioGaia AB (publ)
127.00
-0.31%